Royal College of Pathologists Urges New Zealand to Reconsider Cigarette Sales Ban
According to media outlet scoop.co.nz, the Royal College of Pathologists of Australasia (RCPA) has called for the New Zealand government to reconsider its decision to repeal a law banning the sale of cigarettes nationwide.
Dr. Elizabeth Roberts, the Deputy Director of the Royal College of Pathologists of Australia and New Zealand, believes that this is a setback for public health.
She stated that smoking is the leading preventable cause of death in New Zealand, and the previous government's legislation provided opportunities for disease prevention, reduction and saving lives, particularly benefiting the Māori population who face health inequalities. New Zealand was set to become the first country in the world to achieve a "smoke-free generation," making the current government's change of direction difficult to comprehend.
According to reports, the original measures included banning the sale of tobacco to individuals born after January 1, 2009, limiting nicotine content in tobacco products, and reducing tobacco retailers by over 90%.
Dr. Roberts expressed his deep anguish, saying, "We had believed that the goal of a smoke-free 2025 seemed within our grasp, but now it feels out of reach. We urge the government to reconsider its decision to lift the ban.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
